# Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis

> **NCT03204721** · NA · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 158 (actual)

## Conditions studied

- Graft-Versus-Host Disease

## Interventions

- **OTHER:** Extracorporeal photophoresis (ECP)

## Key facts

- **NCT ID:** NCT03204721
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-21
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204721, "Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03204721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*